Barclays’s iKang Healthcare Group, Inc. KANG Stock Holding History

Barclays’s Portfolio KANG Stock Details KANG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-93,300	Closed	-$1.86M	–	7522
2018 Q1	$1.86M	Buy	93,300 +2,400	+3%	+$40.4K	﹤0.01%	2533
2017 Q4	$1.44M	Buy	90,900 +59,000	+185%	+$852K	﹤0.01%	2759
2017 Q3	$430K	Buy	31,900 +2,600	+9%	+$34.8K	﹤0.01%	3769
2017 Q2	$360K	Buy	+29,300	New	+$425K	﹤0.01%	3844

Barclays's KANG Position: Q1 2019 in Review

Barclays sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 14,909 shares — an estimated $304K sold.

Barclays first reported a position in KANG in Q2 2015 and held it in 14 quarters. The position peaked at $3.9M in Q4 2015. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.

Barclays reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
Barclays sold 14,909 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $304K.
Barclays first reported a position in iKang Healthcare Group, Inc. in Q2 2015 and held it in 14 quarters.
Barclays's iKang Healthcare Group, Inc. position peaked at $3.9M in Q4 2015.
0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.

Based on Barclays's 13F filing for Q1 2019, filed 15 May 2019.